Johnson & Johnson Consumer Inc. misrepresents Neutrogena T/Sal Therapeutic Shampoo as “Preservative Free,” while in actuality the product contains citric acid, “a well-known preservative commonly used in hair products.”
‘No Preservatives’ Class Actions Come For Cosmetics; Neutrogena ‘Preservative Free’ Shampoo Targeted
The plaintiffs’ bar may be turning its sights on cosmetics companies after focusing primarily on food and beverage firms in recent years with class actions alleging preservative-free fraud. The trend accelerated after Celsius Holdings, Inc. settled a related case last year to the tune of $7.8m.
More from Legal
Despite questions surrounding the SEC rule, including disputes being litigated in the US Eighth Circuit, companies must prepare to meet the new climate disclosure requirements in addition to related mandates in California and abroad. Experts emphasize opportunities beyond compliance.
California authorities say predominance of retailers licensed to sell hemp are compliant with ban published effective on 3 October through emergency regulation. But hemp industry’s contesting the regulation in state court, arguing state authorities inappropriately used emergency action to change state law on hemp products legislature passed in 2021.
Plaintiffs in California federal courts seek restitution, damages, and other relief on behalf of themselves and consumers nationwide, whom allegedly were deceived by “Plant-Based” representations on Aveeno and Neutrogena Makeup Removing Wipes.
Filed on 20 August by Pensacola, FL-based law firm Aylstock, Witkin, Kreis & Overholtz (AWKO) on behalf of an unnamed client, the petition points to benzene study data unconnected to Valisure on unheated benzoyl peroxide products, but is light on details of how it was conducted.
More from Policy & Regulation
Namandje Bumpus' departure means there is no obvious, internal candidate to serve as acting commissioner when President-elect Donald Trump takes office in January and the Senate works to confirm a new leader.
The Biden Administration’s final unified agenda sets target dates for three notices of proposed rulemakings under MoCRA, setting a proposal for cosmetic GMPs for October 2025.
FDA publishes an updated registration guidance in the Federal Register 12 December to answer outstanding questions by stakeholders, including whether a single FEI number can be used for multiple related facilities.